Evidence map›Paper›PMID 30836952›Full record

ArticleBMC geriatrics2019

Use of renal risk drugs in a nation-wide Polish older adult population: an analysis of PolSenior database.

Ewa Deskur-Śmielecka, Jerzy Chudek, Agnieszka Neumann-Podczaska, Małgorzata Mossakowska, Barbara Wizner, Katarzyna Wieczorowska-Tobis

Open access · goldAbstract read
In one paragraph

Article in BMC geriatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ewa Deskur-ŚmieleckaChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Hospicjum Palium, os. Rusa 55, 61-245, Poznan, Poland. edeskur@ump.edu.pl.ORCID 0000-0001-8159-3925
Jerzy ChudekDepartment of Internal Medicine and Oncological Chemotherapy, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland.
Agnieszka Neumann-PodczaskaChair of Geriatrics and Gerontology, Poznan University of Medical Sciences, Poznan, Poland.
Małgorzata MossakowskaInternational Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.
Barbara WiznerDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland.
Katarzyna Wieczorowska-TobisChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Hospicjum Palium, os. Rusa 55, 61-245, Poznan, Poland.
Poznan University of Medical Sciences · PLInternational Institute of Molecular and Cell Biology · PLJagiellonian University · PLMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNumerous medications should be avoided, or require dose adjustment in subjects with impaired kidney function. We aimed to assess the prevalence of potentially inappropriate use of renal risk drugs in a nation-wide, community-dwelling Polish older adult population.

methodsWe analysed regular intake of 38 medications that should be avoided, requiring dose modification, increase the risk of pre-renal kidney injury, or may cause potassium retention in subjects with moderately to severely impaired renal function in the PolSenior data base (N = 4514, mean age 76 ± 11 yrs). Kidney function was assessed with short Modification of Diet in Renal Disease formula estimated glomerular filtration rate (sMDRD) and Cockcroft-Gault creatinine clearance (CC).

resultsThere were 855 (19%) individuals with sMDRD < 60 ml/min/1.73m

conclusionsUse of drugs that should be avoided or require dose adjustment due to renal impairment, and potentially inappropriate drug combinations is a common problem in older adults in Poland. Assessment of kidney function with sMDRD may result in overlooking of requirements for dose adjustment formulated based on creatinine clearance.

trial registrationNot applicable.

Indexed as

Geriatric AssessmentAgedAged, 80 and overCommunity Health PlanningDatabases, FactualDrug Dosage CalculationsDrug-Related Side Effects and Adverse ReactionsFemaleGlomerular Filtration RateHumansKidney Function TestsMalePolandRenal InsufficiencyRetrospective StudiesChronic kidney diseaseDosage adjustmentDrug combinationsInappropriate drug useOlder adults

Identifiers

PMID30836952
PMCPMC6402145
OpenAlexW2927936189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.